PAD inhibitors have demonstrated immense potential in the field of cancer therapy, with PAD4 inhibitors in particular being applied to prevent tumor metastasis and associated thrombosis in cancer patients.103 Histone cit by PAD is increasingly recognized as a diagnostic marker and treatment target in cancer research. The gene discussed is PADI4; the disease is cancer.